ObsEva Q&A: addressing unmet needs in women’s health
Swiss biopharmaceutical company ObsEva is focused on developing novel therapeutics for reproductive health and pregnancy.
Parkinson’s disease: could a vaccine be on the horizon?
Academics and pharmaceutical companies alike are working to develop vaccines that could prevent the development...
Setback for Kyowa’s Nouryant in European Parkinson’s disease market – register for free webinar
Join GlobalData on 3 August at 4pm BST for a free webinar on the evolving Parkinson's disease market.
Pharmaceutical Technology Excellence Awards 2021 – DEADLINE EXTENDED TO AUGUST 6
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the industry. The submission deadline for this year's awards has been extended to August 6.
Covid-19 vaccine mixing: has AZ/Pfizer emerged as a winning combo?
Recent studies have suggested a mix-and-match approach to vaccine dosing could induce a better immune response.
Latest Deals
-
IpsenPartnership $1BN
-
SanofiMergers & Acquisitions $3.2BN
-
AstellasPartnership $440M
-
Deep GenomicsCapital Raising $180M
-
IpsenPartnership $1BN
-
SanofiMergers & Acquisitions $3.2BN
-
AstellasPartnership $440M
-
Deep GenomicsCapital Raising $180M
Weekly chart
Top pharma organisations by patents granted in Q2 2021
Pharma groups ranked by patents granted in Q2 2021
| Assignee | Patents |
|---|---|
| F. Hoffmann-La Roche Ltd | 341 |
| Johnson & Johnson | 305 |
| Zhejiang University | 270 |
| Chinese Academy of Sciences | 224 |
| Bristol-Myers Squibb Co | 181 |
| Novartis AG | 178 |
| E. Merck KG | 170 |
| Sanofi | 146 |
| Pfizer Inc | 143 |
| Bayer AG | 105 |
Latest News
Roche secures FDA priority review for Tecentriq in lung cancer indication
The regulatory agency is reviewing the drug’s sBLA application under the Real-Time Oncology Review pilot programme.
Amgen to set up $550m manufacturing plant in Holly Springs, US
Construction of the biomanufacturing facility will start by December and create up to 355 full-time jobs by 2029.
Lilly-Incyte’s baricitinib reduces mortality in Phase III Covid-19 trial
In the second quarter of 2021, Lilly’s Covid-19 antibodies fetched $148.9m in global revenue.
Ipsen and Exicure to develop therapies for neurodegenerative disordersÂ
The partnership will leverage Exicure’s technology and capabilities along with Ipsen’s expertise in neuroscience.
Latest Themes
Sweep Helps Enterprises to Manage Indirect Carbon Emissions
Concept: French startup Sweep has developed an online tool to simplify the process of collecting...
Memorial University Derives Biodegradable Plastic Alternative from Fish Waste
Concept: Researchers at Canada’s Memorial University of Newfoundland (MUN) have developed a greener alternative to...
Supernormal Offers AI-Augmented Asynchronous Video Messaging
Concept: Sweden-based startup SuperNormal has rolled out an AI-powered asynchronous communication tool to improve remote...
OpenSensors Uses Big Data to Enhance Workplace Safety
Concept: London-based OpenSensors has offered sensor-based data-powered solutions to enterprises to assist them to optimize...
Dell Debuts 5G Edge Computing for Network Optimization
Concept: Dell Technologies, VMware and SK Telecom have partnered to develop a new edge computing...
Strata Identity Offers Identity Management for Multi-Cloud Environment
Concept: Colorado-based distributed multi-cloud identity orchestration company Strata Identity assists companies to manage identity and...
Imperva Offers Sonar-Based Security Analytics
Concept: US-based risk management solutions provider Imperva has launched its Sonar platform in beta to...
SecurityScorecard Offers Cybersecurity Ratings for Enterprises
Concept: US-based SecurityScorecard is a cybersecurity rating and risk-monitoring platform that provides companies with security...
Expert Commentary & Analysis
View MoreConcerns over safety on fertility are unfounded for Covid-19 vaccines
Recent studies have demonstrated that concerns that Covid-19 vaccines affect fertility in both men and...
Johnson and Johnson’s Covid-19 vaccine has another problematic rare side effect
As of 30 June, there have been 100 preliminary reports of Guillain-Barré syndrome in the...
IMF issues a historic allocation of SDRs – leading macroeconomic influencers
The Board of Governors of the IMF have approved SDRs equal to $650bn billion to...
Pfizer and Moderna Covid-19 vaccines usage and updated safety labels
New reports indicate an increased risk of myocarditis or pericarditis after being given either of...